In this episode of the Applied Clinical Trials Brief, we recap our three most-viewed stories of the week—covering the Supreme Court’s decision to uphold NIH funding cuts tied to DEI, Phase II data ...

This explainer unpacks how recent US policy shifts are reshaping diversity, equity, and inclusion in clinical research, ...

Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...

Results from the Phase II OptiTROP-Lung01 trial (NCT05351788) showed that Sichuan Kelun-Biotech’s sac-TMT combined with ...

In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...

A new exploratory study will evaluate the safety of Anktiva in patients with long COVID, with secondary and exploratory ...

With approval to proceed, the Phase II trial (NCT06092034) of RP-A501 for Danon disease restarts under an optimized dosing ...

In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...

In this episode of the Applied Clinical Trials Brief, we recap our three most-viewed articles of the week—featuring updated ...

Results from the Phase II COLLECTiVE202 trial (NCT05370885) demonstrated a statistically significant difference between VE202 ...

In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...

An overview of how recent funding reductions are reshaping clinical trial operations, from site sustainability and patient ...